Institut National de la Santé Et de la Recherche Médicale, France
inserm.frTotal trials
371
Active
104
Phase 3
15
Total enrollment
789,928
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 19 of 19 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Lidocaine 20mg/ml | — | — | — | — | — | 1 | |
| Levobupivacaine Hydrochloride 1.25 MG/ML | — | — | — | — | — | 1 | |
| Sodium Chloride 0.9% Inj | — | — | — | — | — | 1 | |
| salivary collections of amylase and cortisol | — | — | — | — | — | 1 | |
| LBT-999 | — | — | — | — | — | 1 | |
| COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | — | — | — | — | — | 1 | |
| Favipiravir | — | — | — | — | 3 | ||
| Blood sampling | — | — | — | — | — | 2 | |
| DNA from subjects will be stored in the biobank of our study. | — | — | — | — | — | 1 | |
| Optical Genome Mapping | — | — | — | — | — | 1 | |
| Longread sequencing | — | — | — | — | — | 1 | |
| blood sample | — | — | — | — | — | 1 | |
| Lumbar puncture | — | — | — | — | — | 1 | |
| blood draw | — | — | — | — | — | 1 | |
| Blood sample collection; gastrointestinal biopsy | — | — | — | — | — | 1 | |
| genetic restrospective study | — | — | — | — | — | 1 | |
| Belatacept Injection [Nulojix] | — | — | — | — | — | 1 | |
| Collection of a salivary sample | — | — | — | — | — | 1 | |
| Collection of samples | — | — | — | — | — | 1 |
Next readouts
- 2022-02-19
- 2024-10-04
- 2025-03-26
- 2025-05-14
- 2026-08-12
- 2026-09-08
- 2027-01-07
- 2027-03-25
- 2027-06
- 2027-06-09
Top conditions
- Parkinson's Disease11
- Healthy11
- Stroke9
- Parkinson Disease9
- Huntington Disease7
- Influenza5
- Obesity5
- Multiple Sclerosis5
Frequently asked questions about Institut National de la Santé Et de la Recherche Médicale, France
- How many clinical trials does Institut National de la Santé Et de la Recherche Médicale, France have on ClinicalTrials.gov?
- Institut National de la Santé Et de la Recherche Médicale, France is listed as the lead sponsor on 371 clinical trials in ClinicalTrials.gov, 104 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Institut National de la Santé Et de la Recherche Médicale, France's trials are in Phase 3?
- 15 of Institut National de la Santé Et de la Recherche Médicale, France's trials are in Phase 3, spread across 19 active drug programs.
- What therapeutic areas does Institut National de la Santé Et de la Recherche Médicale, France focus on?
- Institut National de la Santé Et de la Recherche Médicale, France's most-studied conditions on ClinicalTrials.gov are Parkinson's Disease, Healthy, Stroke, Parkinson Disease, Huntington Disease.
- When are Institut National de la Santé Et de la Recherche Médicale, France's next clinical trial readouts?
- Institut National de la Santé Et de la Recherche Médicale, France has 10 upcoming primary-completion readouts tracked here; the soonest is “Population Genomic Diversity of France”, expected around 2022-02-19.